DK1073467T3 - Formuleringer med co-oplösningsmiddel omfattende en forbindelse af vitamin D - Google Patents
Formuleringer med co-oplösningsmiddel omfattende en forbindelse af vitamin DInfo
- Publication number
- DK1073467T3 DK1073467T3 DK99914970T DK99914970T DK1073467T3 DK 1073467 T3 DK1073467 T3 DK 1073467T3 DK 99914970 T DK99914970 T DK 99914970T DK 99914970 T DK99914970 T DK 99914970T DK 1073467 T3 DK1073467 T3 DK 1073467T3
- Authority
- DK
- Denmark
- Prior art keywords
- vitamin
- compound
- solvent formulations
- formulations
- solvent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/057,143 US6136799A (en) | 1998-04-08 | 1998-04-08 | Cosolvent formulations |
EP99914970A EP1073467B1 (en) | 1998-04-08 | 1999-03-22 | Co-solvent formulations comprising a vitamin d compound |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1073467T3 true DK1073467T3 (da) | 2005-01-03 |
Family
ID=22008769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99914970T DK1073467T3 (da) | 1998-04-08 | 1999-03-22 | Formuleringer med co-oplösningsmiddel omfattende en forbindelse af vitamin D |
Country Status (11)
Country | Link |
---|---|
US (2) | US6136799A (ru) |
EP (1) | EP1073467B1 (ru) |
JP (4) | JP4664499B2 (ru) |
AT (1) | ATE275974T1 (ru) |
AU (1) | AU758989B2 (ru) |
CA (1) | CA2326198C (ru) |
DE (1) | DE69920201T2 (ru) |
DK (1) | DK1073467T3 (ru) |
ES (1) | ES2229693T3 (ru) |
PT (1) | PT1073467E (ru) |
WO (1) | WO1999051271A2 (ru) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6586661B1 (en) | 1997-06-12 | 2003-07-01 | North Carolina State University | Regulation of quinolate phosphoribosyl transferase expression by transformation with a tobacco quinolate phosphoribosyl transferase nucleic acid |
US6136799A (en) * | 1998-04-08 | 2000-10-24 | Abbott Laboratories | Cosolvent formulations |
AU2002230691A1 (en) * | 2000-11-07 | 2002-05-21 | North Carolina State University | Putrescine-n-methyltransferase promoter |
EA008072B1 (ru) * | 2001-12-03 | 2007-02-27 | Новацея, Инк. | Фармацевтические составы, содержащие соединения активного витамина d |
DE60325459D1 (de) | 2002-02-19 | 2009-02-05 | Resolution Chemicals Ltd | Auf lösungsmitteln basierende sterilisation von steroiden |
US20040058895A1 (en) * | 2002-09-18 | 2004-03-25 | Bone Care International, Inc. | Multi-use vessels for vitamin D formulations |
US7148211B2 (en) * | 2002-09-18 | 2006-12-12 | Genzyme Corporation | Formulation for lipophilic agents |
US20040053895A1 (en) * | 2002-09-18 | 2004-03-18 | Bone Care International, Inc. | Multi-use vessels for vitamin D formulations |
US20050026877A1 (en) * | 2002-12-03 | 2005-02-03 | Novacea, Inc. | Pharmaceutical compositions comprising active vitamin D compounds |
US20050020546A1 (en) * | 2003-06-11 | 2005-01-27 | Novacea, Inc. | Pharmaceutical compositions comprising active vitamin D compounds |
US20060189586A1 (en) * | 2003-06-11 | 2006-08-24 | Cleland Jeffrey L | Pharmaceutical compositions comprising active vitamin D compounds |
US20050148557A1 (en) * | 2003-07-29 | 2005-07-07 | Jin Tian | Use of Vitamin Ds to treat kidney disease |
US20060009425A1 (en) * | 2004-05-28 | 2006-01-12 | Leticia Delgado-Herrera | Oral formulations of paricalcitol |
WO2007011951A2 (en) * | 2005-07-18 | 2007-01-25 | Teva Pharmaceutical Industries Ltd. | Purification of paricalcitol |
US20070166187A1 (en) * | 2006-01-18 | 2007-07-19 | Song Jing F | Stabilization of paricalcitol using chlorobutyl or chlorinated butyl stoppers |
CA2651283A1 (en) * | 2006-05-15 | 2007-11-22 | Wisconsin Alumni Research Foundation | Pulmonary delivery of 1.alpha.,25-dihydroxyvitamin d3 and co-administration of parathyroid hormone or calcitonin |
US20100075933A1 (en) * | 2008-07-28 | 2010-03-25 | Sunita Vijay Shelke | Injectable compositions of vitamin d compounds |
US20110033529A1 (en) * | 2009-08-06 | 2011-02-10 | Durga Prasad Samantaray | Oral pharmaceutical paricalcitol formulations |
EP2545940A1 (de) * | 2011-07-14 | 2013-01-16 | hameln rds gmbh | Parenterale Zusammensetzungen |
AU2013281217B2 (en) | 2012-06-29 | 2017-03-02 | Wisconsin Alumni Research Foundation | Use of 2-methylene-19-nor-(20S)-1alpha,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism |
EP2749266B1 (en) * | 2012-12-27 | 2018-08-29 | Pharmathen S.A. | Stable injectable pharmaceutical composition of vitamin D receptor agonist and process for preparation thereof |
US10369161B2 (en) | 2014-12-30 | 2019-08-06 | Wisconsin Alumni Research Foundation | Use of 2-methylene-19-NOR-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat primary hyperparathyroidism |
US9539264B2 (en) | 2014-12-30 | 2017-01-10 | Wisconsin Alumni Research Foundation | Use of 2-methylene-19-nor-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism in patients previously treated with calcimimetics |
CN106265492B (zh) * | 2015-06-04 | 2020-12-11 | 成都国为生物医药有限公司 | 一种含有帕立骨化醇的药物组合物及其制备方法 |
WO2018044468A1 (en) | 2016-08-30 | 2018-03-08 | Wisconsin Alumni Research Foundation | COMBINATION OF LOW DOSE 2-METHYLENE-19-NOR-(20S)-1α, 25-DIHYDROXYVITAMIN D3 AND CALCIMIMETICS TO TREAT SECONDARY HYPERPARATHYROIDISM |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4198391A (en) * | 1973-07-20 | 1980-04-15 | R. P. Scherer Ltd. | Pharmaceutical compositions |
US4212886A (en) * | 1978-11-01 | 1980-07-15 | Survival Technology, Inc. | Stabilized benactyzine hydrochloride |
US4308264A (en) * | 1981-01-28 | 1981-12-29 | Abbott Laboratories | Stabilized, dilute aqueous preparation of 1α,25-dihydroxycholecalciferol for neonatal administration |
DE3316510A1 (de) * | 1983-05-06 | 1984-11-08 | Bayer Ag | Parenterale formulierung von nimodipin, ein verfahren zu ihrer herstellung sowie ihre verwendung bei der bekaempfung von erkrankungen |
US4588528A (en) * | 1984-05-31 | 1986-05-13 | Wisconsin Alumni Research Foundation | 1,24-dihydroxy-Δ22 -vitamin D3 and process for preparing same |
DE3437232A1 (de) * | 1984-10-10 | 1986-04-17 | Mack Chem Pharm | Stabilisierte injektionsloesungen von piroxicam |
US4594340A (en) * | 1984-11-29 | 1986-06-10 | Hoffmann-La Roche Inc. | 25,26-dehydro-1α,24R-dihydroxycholecalciferol and 25,26-dehydro-1α,24S-dihydroxycholecalciferol and the epimeric mixture |
US4855294A (en) * | 1988-09-06 | 1989-08-08 | Theratech, Inc. | Method for reducing skin irritation associated with drug/penetration enhancer compositions |
US5098899A (en) * | 1989-03-06 | 1992-03-24 | Trustees Of Boston University | Method for therapeutically treating psoriatic arthritis using vitamin D analogues and metabolites |
DK191889D0 (da) * | 1989-04-20 | 1989-04-20 | Bukh Meditec | Kosmetisk middel |
AU649057B2 (en) * | 1990-08-24 | 1994-05-12 | Wisconsin Alumni Research Foundation | Methods and compositions containing vitamin D compounds for improvement of skin conditions |
US5502224A (en) * | 1991-06-04 | 1996-03-26 | Marigen, S.A. | Biotenside esters and phosphatides with vitamin-D and vitamin-E compounds |
FR2677884B1 (fr) * | 1991-06-20 | 1993-07-09 | Oreal | Composition pour freiner la chute des cheveux a base de pyrimidines n-oxyde trisubstitues ou leurs derives sulfoconjugues, nouveaux composes pyrimidines n-oxyde ou leurs derives sulfoconjugues. |
JPH06509072A (ja) * | 1991-06-28 | 1994-10-13 | ユニバーシティー、オブ、マイアミ | 化学療法により誘発される脱毛の予防および治療法 |
GB9201920D0 (en) * | 1992-01-29 | 1992-03-18 | Leo Pharm Prod Ltd | Novel treatment i |
JPH05246891A (ja) * | 1992-03-09 | 1993-09-24 | Kobayashi Seiyaku Kogyo Kk | 安定な抗膵炎用注射液 |
KR960013798B1 (ko) * | 1992-04-24 | 1996-10-10 | 재단법인 한국전자통신연구소 | 평면 도파로형 공간 스위치 |
WO1996036340A1 (en) * | 1995-05-19 | 1996-11-21 | Abbott Laboratories | STABLE AQUEOUS FORMULATIONS OF 1α,25-DIHYDROXYCHOLECALCIFEROL FOR PARENTERAL ADMINISTRATION |
US5597815A (en) * | 1995-07-13 | 1997-01-28 | Wisconsin Alumni Research Foundation | Prevention of hyperphosphatemia in kidney disorder patients |
PT892638E (pt) * | 1996-04-04 | 2003-03-31 | Cilag Ag | Formulacao topica de vitamina d a base de lipossomas |
EP0893121B1 (en) * | 1997-06-27 | 2002-03-13 | Akzo Nobel N.V. | Oral liquid medicine solution |
CA2211949A1 (en) * | 1997-07-21 | 1999-01-29 | David Farley Johnson | Nonaqueous compositions for parenteral administration |
US6136799A (en) * | 1998-04-08 | 2000-10-24 | Abbott Laboratories | Cosolvent formulations |
-
1998
- 1998-04-08 US US09/057,143 patent/US6136799A/en not_active Expired - Lifetime
-
1999
- 1999-03-22 EP EP99914970A patent/EP1073467B1/en not_active Expired - Lifetime
- 1999-03-22 JP JP2000542041A patent/JP4664499B2/ja not_active Expired - Lifetime
- 1999-03-22 AU AU33598/99A patent/AU758989B2/en not_active Ceased
- 1999-03-22 PT PT99914970T patent/PT1073467E/pt unknown
- 1999-03-22 CA CA002326198A patent/CA2326198C/en not_active Expired - Lifetime
- 1999-03-22 ES ES99914970T patent/ES2229693T3/es not_active Expired - Lifetime
- 1999-03-22 AT AT99914970T patent/ATE275974T1/de active
- 1999-03-22 WO PCT/US1999/006196 patent/WO1999051271A2/en active IP Right Grant
- 1999-03-22 DE DE69920201T patent/DE69920201T2/de not_active Expired - Lifetime
- 1999-03-22 DK DK99914970T patent/DK1073467T3/da active
-
2000
- 2000-10-12 US US09/689,507 patent/US6361758B1/en not_active Expired - Lifetime
-
2010
- 2010-09-16 JP JP2010207684A patent/JP5548079B2/ja not_active Expired - Lifetime
-
2014
- 2014-01-31 JP JP2014016658A patent/JP5887368B2/ja not_active Expired - Lifetime
-
2015
- 2015-10-16 JP JP2015204318A patent/JP2016053046A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE69920201D1 (de) | 2004-10-21 |
WO1999051271A3 (en) | 1999-11-18 |
EP1073467A2 (en) | 2001-02-07 |
CA2326198C (en) | 2009-06-09 |
JP5887368B2 (ja) | 2016-03-16 |
WO1999051271A2 (en) | 1999-10-14 |
JP2011037860A (ja) | 2011-02-24 |
AU3359899A (en) | 1999-10-25 |
AU758989B2 (en) | 2003-04-03 |
JP2002510652A (ja) | 2002-04-09 |
JP5548079B2 (ja) | 2014-07-16 |
US6361758B1 (en) | 2002-03-26 |
JP2016053046A (ja) | 2016-04-14 |
US6136799A (en) | 2000-10-24 |
PT1073467E (pt) | 2004-12-31 |
DE69920201T2 (de) | 2005-09-29 |
EP1073467B1 (en) | 2004-09-15 |
ATE275974T1 (de) | 2004-10-15 |
ES2229693T3 (es) | 2005-04-16 |
CA2326198A1 (en) | 1999-10-14 |
JP4664499B2 (ja) | 2011-04-06 |
JP2014129360A (ja) | 2014-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1073467T3 (da) | Formuleringer med co-oplösningsmiddel omfattende en forbindelse af vitamin D | |
FI964583A0 (fi) | Tokoferolikoostumuksia biologisesti aktiivisten aineiden antamiseksi | |
ATE216590T1 (de) | Arzneimittelformulierungen für il-12 | |
DK0991407T3 (da) | Stabilisering af syresensitive benzimidazoler med amino/cyclodextrin-kombinationer | |
BR0215184A (pt) | composições farmacêuticas de derivados de taxano oralmente ativos tendo biodisponibilidade aumentada | |
BR9914251A (pt) | Formulações orais de liberação sustentada | |
NO991152D0 (no) | Stabil farmas°ytisk blanding inneholdende 4,5-epoksy-morfinan-derivat | |
DK1033981T3 (da) | Formuleringer og fremgangsmåder til nedsættelse af antineoplastiske midlers toksicitet | |
DK1021204T3 (da) | Bioadhæsive præparater og fremgangsmåder til topisk administration af aktive midler | |
BR9611802A (pt) | Composições farmacêuticas | |
CL2009001682A1 (es) | Composición farmacéutica espontáneamente dispersable para administración oral que comprende n-benzoil-estaurosporina; método para incrementar los niveles de biodisponibilidad. (divisional de la solocitud 333-00). | |
BR9810495A (pt) | Composição farmacêutica | |
ITFI930247A1 (it) | Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche. | |
SE8804629D0 (sv) | New therapeutically active compounds | |
TR199801861T2 (xx) | Farmas�tik olarak yararl� bile�imler. | |
DE60019334D1 (de) | Antivirale arznei | |
CY1106633T1 (el) | Φαρμακευτικες συνθεσεις οι οποιες περιεχουν χαλκο, σαλικυλικο οξυ και βιταμινη c | |
IS2258B (is) | Setin tríasóló-pýridasín afleiða, lyfjasamsetningar gerðar úr henni | |
DK1280558T3 (da) | Halvfast indgivelsesvehikel og farmaceutiske sammensætninger | |
DK122191D0 (da) | Benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme | |
BRPI9916820B8 (pt) | composição compreendendo 9[2[[bis[(pivaloilóxi)metil]fosfono]metóxi]etil]adenina, comprimido ou cápsula e método | |
TR200200683T2 (tr) | Oral kontrollü salıverme formülasyonları. | |
ES2192789T3 (es) | Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios. | |
DK1061938T3 (da) | Orale sammensætninger med cytotoksiske proteiner i lav dosis | |
IT1255969B (it) | Formulazioni di acido ursodesossicolico a rilascio controllato |